Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 7/20 | 0.31 |
| ▸ | DRD3 | P35462 | 7/20 | 0.31 |
| ▸ | DRD2 | P14416 | 6/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337555 | 1.00 | DPP4 (0.33) | DPP4DPP7TDP1GRM1ALOX5 | |
| SCHEMBL337586 | 1.00 | DPP4 (0.33) | DPP4DPP7TDP1GRM1ALOX5 | |
| SCHEMBL338510 | 1.00 | DPP4 (0.33) | DPP4DPP7TDP1GRM1ALOX5 | |
| SCHEMBL1967077 | 1.00 | DPP4 (0.33) | DPP4DPP7TDP1GRM1ALOX5 | |
| SCHEMBL338513 | 0.89 | DPP4 (0.41) | DPP4DPP7ALOX5MAPK8SLC1A3 | |
| SCHEMBL3642588 | 0.89 | DPP4 (0.41) | DPP4DPP7ALOX5MAPK8SLC1A3 | |
| SCHEMBL1966898 | 0.88 | GRM1 (0.38) | TDP1GRM1ALOX5EPHX2HSD11B1 | |
| SCHEMBL337044 | 0.88 | GRM1 (0.38) | TDP1GRM1ALOX5EPHX2HSD11B1 | |
| SCHEMBL6180497 | 0.82 | GRM1 (0.32) | DPP4DPP7GRM1HTR2ADRD3 | |
| SCHEMBL10086737 | 0.81 | BRD4 (0.41) | GRM1HTR2ADRD3DRD2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097637-B2 | Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors | HOFFMANN-LA ROCHE INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-20090042943-A1 | BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS | HOFFMANN-LA ROCHE, INC. | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042943-A1 | BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS | HTR2A, HTR3A, HTR5A | DPP4 2519/4885DPP7 3052/4885TDP1 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.